Cell line name NCC-UPS3-C1
Accession CVCL_B3RN
Resource Identification Initiative To cite this cell line use: NCC-UPS3-C1 (RRID:CVCL_B3RN)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: 61.6 hours (PubMed=34665443).
Omics: SNP array analysis.
Derived from site: Metastatic; Left buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
Sequence variations
Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Unspecified (PubMed=34665443).
Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Unspecified (PubMed=34665443).
Disease Undifferentiated pleomorphic sarcoma (NCIt: C4247)
Undifferentiated pleomorphic sarcoma (ORDO: Orphanet_2023)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 55Y
Category Cancer cell line
STR profile

Source(s): PubMed=34665443


Amelogenin X
CSF1PO 10,11,12
D5S818 11,12,13
D7S820 10,11
D13S317 10,12
D16S539 9,10
D21S11 29,31
TH01 9,9.3
vWA 17,20,21,22

PubMed=34665443; DOI=10.1007/s13577-021-00633-w
Tsuchiya R., Yoshimatsu Y., Noguchi R., Sin Y., Ono T., Akiyama T., Sugaya J., Nakatani F., Kojima N., Yoshida A., Ohtori S., Kawai A., Kondo T.
Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma.
Hum. Cell 35:384-391(2022)

Encyclopedic resources Wikidata; Q110433091

Additional information

User Category

Academia/non-profit organization, For-profit organization


There are no reviews yet.

Be the first to review “NCC-UPS3-C1”

Your email address will not be published. Required fields are marked *